- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Meningococcal disease
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1173KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 117KB)
Meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine
Meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine: Injection 0.5 mL; Menquadfi®
Last updated
8 July 2025